Climb Bio Stock Alpha and Beta Analysis
| CLYM Stock | 2.10 0.17 7.49% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Climb Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Climb Bio over a specified time horizon. Remember, high Climb Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Climb Bio's market risk premium analysis include:
Beta 0.33 | Alpha (1.35) | Risk 4.8 | Sharpe Ratio (0.27) | Expected Return (1.30) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Climb |
Climb Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Climb Bio market risk premium is the additional return an investor will receive from holding Climb Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Climb Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Climb Bio's performance over market.| α | -1.35 | β | 0.33 |
Climb Bio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Climb Bio's Buy-and-hold return. Our buy-and-hold chart shows how Climb Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Climb Bio Market Price Analysis
Market price analysis indicators help investors to evaluate how Climb Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Climb Bio shares will generate the highest return on investment. By understating and applying Climb Bio stock market price indicators, traders can identify Climb Bio position entry and exit signals to maximize returns.
Climb Bio Return and Market Media
The median price of Climb Bio for the period between Tue, Oct 1, 2024 and Mon, Dec 30, 2024 is 3.62 with a coefficient of variation of 28.59. The daily time series for the period is distributed with a sample standard deviation of 1.08, arithmetic mean of 3.77, and mean deviation of 0.93. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024 | 10/11/2024 |
2 | Insider Trading | 11/08/2024 |
3 | Acquisition by Williams Douglas E of 6291 shares of Climb Bio at 4.06 subject to Rule 16b-3 | 11/11/2024 |
4 | Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases - TipRanks | 11/13/2024 |
5 | GitLab Shares Climb After Outlook Raise, Strong 3Q - MarketWatch | 12/06/2024 |
6 | Acquisition by Emily Pimblett of 5000 shares of Climb Bio subject to Rule 16b-3 | 12/18/2024 |
7 | Climb Bio set to join Nasdaq Biotech Index | 12/19/2024 |
About Climb Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Climb or other stocks. Alpha measures the amount that position in Climb Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Climb Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Climb Bio's short interest history, or implied volatility extrapolated from Climb Bio options trading.
Build Portfolio with Climb Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Climb Bio Backtesting, Climb Bio Valuation, Climb Bio Correlation, Climb Bio Hype Analysis, Climb Bio Volatility, Climb Bio History and analyze Climb Bio Performance. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Climb Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.